Background: Identifying genetic relationships between complex traits in emerging adulthood can provide useful 29 etiological insights into risk for psychopathology. College-age individuals are under-represented in genomic 30 analyses thus far, and the majority of work has focused on clinical disorder or cognitive abilities rather than normal-31 range behavioral outcomes. 32 Methods: This study examined a sample of emerging adults 18-22 years of age (N = 5,947) to construct an atlas of 33 polygenic risk for 33 traits predicting real-world outcomes. Twenty-eight hypotheses were tested based on the 34 previous literature on samples of European ancestry, and the availability of rich assessment data allowed for 35 polygenic predictions across 55 psychological and medical phenotypes.
45
Introduction 46 Broad phenotyping can greatly enhance our understanding of the underlying structure of genetic 47 vulnerability to psychiatric disorders. Recent genome-wide polygenic risk research has utilized a range of clinical 48 traits (the "phenome") (Bulik-Sullivan et al. 2015; Krapohl et al. 2015; Hagenaars et al. 2016) . This approach uses 49 published summary statistics from large genome-wide association studies to calculate genome-wide polygenic 50 scores (GPS) for many major disorders and clinically relevant traits. These scores are then used to predict a number 51 of potentially informative psychiatric, psychological and physical health phenotypes. In conjunction with psychiatric 52 genomic cross-disorder research (Cross-Disorder Group of the Psychiatric Genomics Consortium, 2013) examining 53 the co-heritability of major psychiatric disorders (e.g., Docherty et al. 2016 ), this appears to be a promising method 54 for elucidating a genetic framework for psychiatric disorders and discovering unexpected genotype-phenotype 55 associations. However, previous research has not included GPS of eating, anxiety, and inflammatory disorders, 56 personality, lipid levels and puberty traits in the prediction of outcome phenotypes (which have frequently focused 57 on cognitive abilities) and has not examined samples between the ages of 17 and 35, the key age brackets of 58 emerging and young adulthood.
59
This study applied such an approach to GPS (33 total) in a substantial genetic study of emerging adulthood 60 outcomes. Emerging adulthood, a period starting at the age of 18 when adolescents begin to develop the roles and 61 independence of adulthood, reflects a high-risk age range for the onset of many psychiatric and substance use 62 disorders, including schizophrenia, affective disorders, anxiety disorders and alcohol and drug use disorders. Data 63 from the National Comorbidity Survey Replication sample indicate that three quarters of all lifetime cases of DSM-64 IV diagnoses start by age 24 (Kessler et al. 2005) , and WHO's World Mental Health data indicates that data allowed for the calculation of polygenic predictions across a greater number of outcomes than has ever been 73 studied previously, many of which were completely novel in phenomic studies. These included 55 psychiatric, 74 psychological and medical phenotypes (listed in Table S2 in the online supplementary material).
75
Moreover, the GPS metrics were powerful enough to examine relationships across subsamples of different 76 ancestries. While GWAS approaches require thousands of individuals to locate "hits," continuous polygenic scores 77 require far smaller samples for adequate power. This sample was suitably diverse in ancestry to map the GPS-78 phenotype in young adults of European ancestry (EUR, N=3,016) and then to replicate these findings and GPS-GPS 79 correlations across non-European ancestry groups including of African origin (AFR, N=1,339), native American 80 origin (AMR, N=581), and East Asian (EAS, N=557), and South Asian origin (SAS, N=454) . Separate association 81 matrices were created for the empirically categorized AFR, AMR, EAS, and SAS samples and are provided here and 82 in the supplemental figures available online.
83
We can learn a lot from the study of emerging adults over and above adolescent samples, as early 84 behavioral patterns that may precede adult psychopathology can be studied, and new hypotheses about critical 85 exposures and environmental risk factors can emerge. The results presented here reflect a polygenic modeling 86 framework in a large young adult sample, and provides evidence that the integration of phenotypic and genotypic 87 data will be useful in the prediction of negative health outcomes in emerging adults. 
99
Participants were 61.1% female with a mean age of 18.59 at first assessment. Representativeness of this sample is strong and has been reported elsewhere (Dick et al. 2014) . Assignment to ancestry group was empirically based on 101 greatest similarity to 1000 Genomes Phase 3 super-populations. The present analyses included 55 traits from the 102 domains of psychopathology, personality, health factors, and educational achievement ( Table S2 in the online   103 supplementary materials). All analyses included age, sex, and 10 ancestry principal components as covariates.
104
Variables assessed at multiple occasions or in multiple cohorts were adjusted for number of assessments and cohort 105 group. Sample sizes for each of the phenotypic measures are also provided in Table S2 .
106
Genetic Risk Scoring 107 DNA collection, calling, and imputation is detailed elsewhere (Dick et al. 2014) . We processed genotypes 108 using standard quality control procedures followed by imputation of SNPs using the 1000 Genomes Project 109 reference panel. After imputation and quality control, we included approximately 2.3 million variants into the 110 polygenic scoring analyses. A GPS for each discovery phenotype was calculated using the summary statistics we 111 obtained from 33 GWAS ( Table S1 in the online supplementary materials). Python-based LDpred (Vilhjálmsson et 112 al. 2015) was used for these analyses because of its ability to account for linkage disequilibrium (LD) structure 113 (Krapohl et al. 2015) using our own large EUR test sample, and its use of all genetic variants (lack of specified p-114 value threshold for inclusion of the genetic variants in the GPS). LDpred allows for the modeling of LD based on 115 LD in the discovery sample to weight the relative contributions of syntenic variants to the outcome phenotype.
116
LDpred uses postulated proportions of causal variants in the genome as Bayesian prior probabilities for GPS 117 calculations, and we tested a range of different priors (proportions of 0.3, 0.1, 0.03, 0.01, 0.003, and 0.001), as well 118 as the model of infinite variants of infinitesimally small effect (Fisher, 1919) to construct scores.
119

Phenotype Prediction
120
A flowchart depicting the GPS-phenome cross-ancestry prediction and GPS-GPS correlation procedure is presented 121 in Figure 1 . Regressions were run using R to compare full (GPS, ten ancestry principal components, age, sex, 122 cohort, and number of measurements when applicable) and restricted models where GPS was removed. Prior to the 123 global analyses, a set of a priori hypotheses, gathered from previous research, were tested (Table 1) . We elected to 124 forgo experimental binning (into quantiles, for example) in order to minimize the number of exploratory analyses 125 beyond regressions of GPS on the phenotypes. Multiple testing was corrected for using a False Discovery Rate 126 (FDR) of 5% (Benjamini & Hochberg, 1995) within each ancestry group using the p.adjust function in R; the FDR 127 is appropriate for an analysis designed to evaluate the pattern of relationships between many constructs because it treats each combination of discovery phenotype, outcome, and LDpred prior level as an independent test. It should 129 be noted that this multiple testing correction was conservative, not accounting for previously established 130 associations or correlations between multiple prior levels tested in the same discovery phenotypes, to filter out any 131 potentially spurious results.
132
Cross-Disorder GPS Partial Correlations and GPS-GPS Replication Hypotheses Across Ancestry
133
In addition to testing the GPSs prediction of the phenotypes, GPSs were also examined for correlations 134 with each other in all ethnicities. These provide different results than genetic correlation estimates, but are intended 135 to demonstrate that GPS scores are not independent, and that variance attributable to a particular discovery 136 phenotype may be partially shared with another. This sharing may be due to common genetic factors between 137 phenotypes, possible sample overlap, and error variance. GPS correlations have been previously reported in EUR, 138 but this analysis added phenotypes such as cardiovascular and triglyceride factors. Correlation coefficients, p-values, 139 and q-values (after correcting the p-values for the FDR of 5%) were derived for GPS partial correlations using R and 140 adjusting for the ancestry principal components. We chose to use partial correlations in order to standardize the 141 weights across phenotype and provide more direct comparisons of statistics for plotting purposes. Based on the 142 cross-disorder psychiatric genomics findings to date (Bulik-Sullivan et al. 2015) , we hypothesized significant GPS 143 associations between schizophrenia (SZ) and bipolar disorder (BP), SZ and autism (AUT), SZ and major depressive 144 disorder (MDD), BP and MDD, and AUT and attention deficit hyperactivity disorder (ADHD) across each of the 145 ancestry groups (see Table 2 ).
147
Results
148
Genetic Profile Score-Phenotype Prediction
149
A Priori Replication Analyses 150 We evaluated previous cross-phenotype predictions based on recent work-for example, that age at 151 menarche had an inverse association with obesity/body mass index (Bulik-Sullivan et al. 2015) . We tested several 152 hypotheses in the European group, in order to maximize sample size without introducing potential population 153 stratification. Multiple testing correction (FDR) was very conservative; again, we corrected uniformly for the total 154 number of tests. This was to filter out any potentially spurious results. Of the 28 predictions tested, 22 showed 155 effects in the expected direction (p=0.002, one-tailed sign test), and 7 were significant after stringent multiple-testing correction. Two previous notable null associations, MDD GPS predicting Grade Point Average (GPA), and 157 Type 2 Diabetes GPS predicting GPA, were also null in our sample. Full results are presented in Table 1, including   158 additional associations with the listed GPS phenotypes.
159
Phenome-Wide Prediction
160
We also performed hypothesis-free analyses across all 33 GPS and 55 S4S phenotypes to explore 161 potentially novel associations. Multiple prior proportions of causal variants in the genome were tested, as detailed in 162 Methods. Figure 2 presents notable results for GPS prediction of phenotypes in the European group for the prior 163 proportion of 0.3 (that is, an initial assumption that 30% of the genome is associated with the GPS phenotype). The 164 0.3 prior level showed stronger prediction in past work (Krapohl et al. 2015) , and corresponds to a plausible 165 assumption about the genetic architecture of many complex traits, due to instances of increasing sample size of 166 GWAS proportionally increasing numbers of associated loci. In this group and prior proportion level, out of 1,815 167 associations 35 were suggestively significant at q<0.16 (the P-value threshold corresponding to Akaike Information 168 Criterion (Akaike, 1974)), 11 more were significant at q<0.05, and 26 additional associations were robust at q<0.01.
169
An additional 53 associations showed at least suggestive significance at other prior levels. A heatmap of analyses at 170 multiple assumed prior proportions of causal variants can be found in Figure 2 (EUR; and for replications in all 171 ancestries, Figures S1-S4 available in the online supplementary materials). Each plot presents significant 172 associations as well as the direction of predictive effect. Because of the stringent correction for multiple testing, we 173 included of interest q<0.16 associations, which would be significant with more traditional, liberal correction 174 methods accounting for previously established effects.
175
Notable unexpected results included SZ GPS significantly predicting nicotine use, depression and anxiety 176 symptoms, and family history of depression, anxiety, alcohol use disorder, and drug use. In addition, GPS for 177 neuroticism (N) predicted a number of relevant psychiatric phenotypes, including neurotic, depression and anxiety 178 symptoms.
179
Genetic Profile Score Prediction of the Phenome Across Non-European Ancestries
180
As noted earlier, most discovery GWAS have used European samples, and while there is good evidence for 181 cross-ancestral replication for some traits, the generalizability of many of these relationships transethnically is not 182 known. The diverse ancestry groups within S4S allowed cross-ancestral replication, and the use of continuous GPS 183 metrics made the sample sizes available powerful enough to examine these hypotheses. A large proportion of the strongest predictors observed in the EUR were replicated across the other ancestries, with a broadly similar pattern 185 of results across all ancestry groups. While some outcome phenotypes were strongly predicted by GPS, a few 186 outcome phenotypes, including physical activity, lifetime history of panic attack, age at first sexual intercourse, and 187 bulimia nervosa were not predicted by any GPS in any ancestry group.
188
GPS-GPS Correlations
189
A Priori Hypothesis Testing and Global Cross-Disorder Genetic Profile Analyses 190 Based on the cross-disorder psychiatric genomics findings to date, we had hypothesized significant GPS 191 correlations between: SZ and BP, SZ and AUT, SZ and MDD, BP and MDD, and AUT and ADHD across each of 192 the ancestry groups. A priori hypotheses (described in the Methods and listed in Table 2 ) of relationships between 193 GPS scores were tested at a prior proportion level of 0.3. Figure 3 presents the results for GPS-GPS partial 194 correlations at a GPS p = 0.3, and these results are presented because some phenotypes studied here (e.g., N) were disease. There is some overlap between the discovery samples for neuroticism and triglycerides, but no overlapping 199 studies were included in the neuroticism and the coronary artery disease discovery samples. Therefore, the 200 correlation of neuroticism and coronary artery disease is especially likely to reflect underlying genetic correlation 201 between neuroticism and artery disease. Despite overlap in the discovery samples for the neuroticism and 202 triglycerides polygenic scores, validation using LD score regression supported the existence of a genetic relationship 203 between them (r G = 0.53; SE = 0.04; p = 1.5 x 10 -36 ).
205
Discussion
206
The findings here present a wide-ranging and nuanced picture of major dimensions of vulnerability to 207 psychopathology at a genetic level. This study includes substantial sample sizes of emerging adults, uses real-world 208 outcome measures (with novel phenotypes in phenomic analyses; see Table S2 in the online supplement for details 209 of assessment scales), includes a wide range of discovery GWAS, and is powerful enough to draw preliminary 210 conclusions about several ancestries. Because this study does not look for "hits" in the traditional GWAS sense and 211 instead uses continuous GPS metrics, sample sizes provide adequate power across all separate ancestries in this 212 study.
213
Importantly, results reflect relationships between anxiety, depressive, and schizophrenia-spectrum disorders 214 that are largely consistent with current conceptualizations of diagnostic classification, and confirm the important 215 involvement of a network of medical and risk phenotypes in genetic predisposition to these disorders. Informative 
236
Notable unexpected GPS-GPS results included positive correlations of N GPS with GPSs for coronary 237 artery disease, which is likely to reflect underlying genetic correlation, as well as with triglycerides. This is the first 238 study we know of to document significant positive genetic associations between N and cardiac health, despite the high public health cost of N being well-documented (Cuijpers et al. 2010 ; cardiovascular risk and association with 240 psychiatric phenotypes like N may be of special interest to public health efforts). Most of the GPS-GPS a priori 241 relationships chosen for replication testing were represented in the same direction across all ancestry groups, 242 corroborating previous efforts to map relationships between genetic risk profiles.
243
The abundance of significant relationships between intuitive combinations of GPSs and related outcomes is 244 reassuring considering the many factors that could attenuate the statistical link between them. Association between a 245 GPS and an outcome not only reflects correlation between the phenotype in the original ('discovery') GWAS that 246 produced the statistics used to compute the GPS and the outcome phenotype, but is also related to a number of other 247 factors. The link is limited by how accurately the GWAS measured the initial phenotype, how similar the discovery 248 and test samples are (in age, ancestry composition, proportions of each sex, etc.), how well the test phenotype is 249 measured by the data collection instrument, and how well it can incorporate indirect pathways from the genetic 250 architectures to either phenotype.
251
For example, physical activity increases HDL levels (Kokkinos & Fernhall, 1999) , so those who had higher 252 HDL levels in the discovery GWAS (Teslovich et al. 2010) were likely a mix of those with innately high levels, 253 those who engaged in higher levels of physical activity, and those with both traits. Therefore, HDL GPS perhaps 254 indexes some propensity to engage in physical activity or other HDL-promoting behaviors, in addition to HDL 255 metabolic variation such as a slower rate of HDL catabolism, which is thought to be the most common genetically 256 determined mechanism of increased HDL levels in humans (Rader, 2006) . The portion of the HDL GPS due to 257 fitness behaviors may explain some of the polygenic association with the test phenotypes of BMI and weight.
258
There are a number of limitations to be aware of when interpreting these results. The synthesis of 259 information from so many sources compounds any methodological and psychometric issues present in the original 260 studies, so there is probable bias in multiple levels of the analysis that is difficult to measure. In order to maintain 261 proximity with real outcomes, we did not transform our phenotypic variables to increase normality, but standardized 262 the continuous variables computed from the participant responses to maintain comparable ranges of measurement.
263
While LDpred performs adequately across ancestry groups, the accuracy in non-European ancestry groups is 264 attenuated to the degree that multiple causal variants fall in regions where LD patterns differ transethnically. In 265 addition, a recent pre-print (Martin et al. 2016) shows biased predictions in several different populations using GPS 266 for phenotypes that are also used in this paper (for example, Type 2 diabetes and SZ).
Overall, this broader picture of genetic vulnerability has important implications for how we study risk and 268 resilience in emerging adulthood. While the variance explained by any of these GPSs is small, they provide easily 269 accessible information to guide future prediction, prevention, and intervention efforts to improve health and quality 
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